ENDURANCE EXERCISE TRAINING REDUCES GLUCOSE-STIMULATED INSULIN LEVELSIN 60-YEAR-OLD TO 70-YEAR-OLD MEN AND WOMEN

Citation
Jp. Kirwan et al., ENDURANCE EXERCISE TRAINING REDUCES GLUCOSE-STIMULATED INSULIN LEVELSIN 60-YEAR-OLD TO 70-YEAR-OLD MEN AND WOMEN, Journal of gerontology, 48(3), 1993, pp. 84-90
Citations number
44
Categorie Soggetti
Geiatric & Gerontology","Geiatric & Gerontology
Journal title
ISSN journal
00221422
Volume
48
Issue
3
Year of publication
1993
Pages
84 - 90
Database
ISI
SICI code
0022-1422(1993)48:3<84:EETRGI>2.0.ZU;2-O
Abstract
Background. Aging is frequently associated with development of insulin resistance and deterioration of glucose tolerance. Plasma glucose and insulin concentrations tend to be higher than in young people, even i n those older individuals whose glucose tolerance is within the normal range. A sedentary life style could play a role in the development of insulin resistance and hyperinsulinemia with advancing age. Methods. We evaluated the effect of 9 mo of vigorous endurance exercise trainin g (approximately 80% of maximal heart rate) on the glucose-stimulated insulin response and glucose disposal rate, using the hyperglycemic cl amp procedure, in 12 people aged 65 +/- 1 yr (mean +/- SE) with normal glucose tolerance. The post-training hyperglycemic clamps were perfor med approximately 16 h after a usual exercise session. Results. VO2max increased approximately 23% in response to the exercise program. The plasma insulin concentration (I) during hyperglycemia (180 mg.dL-1) wa s significantly lower (mean 36 +/- 6 muU.mL-1 before vs 26 +/- 5 muU.m L-1 after; p < .05) after the exercise program. Insulin action was imp roved by the exercise, as the glucose disposal Tate (M) during hypergl ycemia was unchanged despite the blunted insulin response, resulting i n an increase in the M/I ratio from 24 +/- 5 to 30 +/- 5 (p < .05), a value similar to the M/I ratio of 33 +/- 4 found in normally active yo ung subjects. Conclusion. These results provide evidence that regular exercise is effective in reducing hyperinsulinemia and improving insul in action in 65-yr-olds to levels typical of young people.